Standards Comparison

    FERPA

    Mandatory
    1974

    U.S. federal regulation protecting student education records privacy

    VS

    FDA 21 CFR Part 11

    Mandatory
    1997

    FDA regulation for trustworthy electronic records and signatures

    Quick Verdict

    FERPA protects student education records privacy in schools via access and disclosure rules, while FDA 21 CFR Part 11 ensures electronic records/signatures are trustworthy for life sciences. Schools maintain federal funding; pharma firms avoid enforcement actions.

    Student Privacy

    FERPA

    Family Educational Rights and Privacy Act (FERPA)

    Cost
    €€€
    Complexity
    High
    Implementation Time
    6-12 months

    Key Features

    • Establishes rights to inspect, amend, consent for education records
    • Expansive PII definition including linkable indirect identifiers
    • Enumerated exceptions balancing privacy with school operations
    • Mandates 45-day access timelines and annual rights notices
    • Requires detailed disclosure logging and recordkeeping
    Electronic Records

    FDA 21 CFR Part 11

    21 CFR Part 11 Electronic Records; Electronic Signatures

    Cost
    €€€€
    Complexity
    High
    Implementation Time
    12-18 months

    Key Features

    • Risk-based validation for system accuracy and integrity
    • Secure time-stamped audit trails for all actions
    • Multi-component electronic signatures with non-repudiation
    • Access, authority, and device checks enforced
    • Open system controls with encryption and digital signatures

    Detailed Analysis

    A comprehensive look at the specific requirements, scope, and impact of each standard.

    FERPA Details

    What It Is

    FERPA (Family Educational Rights and Privacy Act of 1974), codified at 20 U.S.C. §1232g with regulations at 34 CFR Part 99, is a U.S. federal regulation safeguarding student education records privacy. It grants parents/eligible students rights to access and control PII, using a consent-based model balanced by enumerated exceptions for educational operations.

    Key Components

    • Core rights: inspect/review within 45 days, amend inaccurate records, prior consent for disclosures
    • Definitions: broad education records (directly related to students, any medium), expansive PII (direct/indirect/linkable identifiers)
    • Disclosures: general consent rule plus exceptions (school officials/LEI, emergencies, audits)
    • Obligations: annual notices, disclosure logs per §99.32, enforcement via complaints/funding leverage

    Why Organizations Use It

    • Mandatory for federally funded schools to retain eligibility and avoid penalties
    • Builds student/parent trust, mitigates breach risks, enables compliant edtech/vendor use
    • Supports data-driven decisions while managing re-identification threats

    Implementation Overview

    • Phased: governance setup, data inventory/classification, policies/training, RBAC/logging, vendor DPAs/audits
    • Targets K-12/postsecondary; ongoing program, no formal certification but DOE audits possible

    FDA 21 CFR Part 11 Details

    What It Is

    FDA 21 CFR Part 11 is a U.S. regulation establishing criteria for electronic records and electronic signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures. It applies to FDA-regulated industries using electronic systems for predicate-rule records, employing a risk-based approach with enforcement discretion on certain elements per 2003 FDA guidance.

    Key Components

    • **Subpart BControls for closed (§11.10) and open (§11.30) systems, including validation, audit trails, access limits, checks, and signatures.
    • **Subpart CElectronic signature requirements (§§11.50-11.300) for uniqueness, manifestation, linking, and multi-component controls.
    • Core principles: authenticity, integrity, non-repudiation; no formal certification, but compliance via validation and SOPs.

    Why Organizations Use It

    • Meets legal requirements for electronic records in pharma, devices, biologics.
    • Mitigates data integrity risks, avoids warning letters.
    • Enables paperless operations, improves efficiency, inspection readiness.
    • Builds stakeholder trust through demonstrable controls.

    Implementation Overview

    • Risk-based scoping, CSV (IQ/OQ/PQ), SOPs, training.
    • Applies to life sciences firms using electronic records; U.S.-focused.

    Key Differences

    Scope

    FERPA
    Student education records privacy and access
    FDA 21 CFR Part 11
    Electronic records/signatures trustworthiness

    Industry

    FERPA
    Educational institutions (K-12, postsecondary)
    FDA 21 CFR Part 11
    Life sciences, pharma, medical devices

    Nature

    FERPA
    Funding-conditioned privacy regulation
    FDA 21 CFR Part 11
    Electronic records equivalency regulation

    Testing

    FERPA
    Disclosure logging, access controls review
    FDA 21 CFR Part 11
    System validation (IQ/OQ/PQ), audit trails

    Penalties

    FERPA
    Federal funding withholding, complaints
    FDA 21 CFR Part 11
    Warning letters, product holds, injunctions

    Frequently Asked Questions

    Common questions about FERPA and FDA 21 CFR Part 11

    FERPA FAQ

    FDA 21 CFR Part 11 FAQ

    You Might also be Interested in These Articles...

    Run Maturity Assessments with GRADUM

    Transform your compliance journey with our AI-powered assessment platform

    Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

    100+ Standards & Regulations
    AI-Powered Insights
    Collaborative Assessments
    Actionable Recommendations

    Check out these other Gradum.io Standards Comparison Pages